Amarin Corporation plc (AMRN) Revenue History
Annual and quarterly revenue from 2013 to 2024
Compound Annual Growth Rate (CAGR)
Loading revenue history...
Revenue Growth Metrics
Revenue Breakdown (FY 2024)
AMRN's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
By Geography
AMRN Revenue Analysis (2013–2024)
As of March 2, 2026, Amarin Corporation plc (AMRN) generated trailing twelve-month (TTM) revenue of $226.7 million, reflecting strong growth of +17.4% year-over-year. The most recent quarter (Q3 2025) recorded $49.7 million in revenue, down 31.7% sequentially.
Looking at the longer-term picture, AMRN's 5-year compound annual growth rate (CAGR) stands at -11.9%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $614.1 million in 2020.
Revenue diversification analysis shows AMRN's business is primarily driven by Product (89%), and Licensing And Royalty (11%). With over half of revenue concentrated in Product, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including UTHR (+10.6% YoY), ZLAB (+15.3% YoY), and ALKS (-5.2% YoY), AMRN has underperformed the peer group in terms of revenue growth. Compare AMRN vs UTHR →
Peer Comparison
Compare AMRN's revenue metrics with industry peers
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AMRNCurrent | $227M | +17.4% | -11.9% | -40.2% | |
| UTHR | $3.2B | +10.6% | +16.5% | 46.9% | |
| ZLAB | $460M | +15.3% | +56.5% | -49.9% | |
| ALKS | $1.5B | -5.2% | +7.3% | 17.2% | |
| ADMA | $426M | +27.6% | +70.8% | 32.6% | |
| ARQT | $376M | +91.3% | - | -3.3% |
Historical Revenue Data
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2024 | $228.6M | -25.5% | $81.4M | 35.6% | $-91,797,000 | -40.2% |
| 2023 | $306.9M | -16.9% | $165.5M | 53.9% | $-67,588,000 | -22.0% |
| 2022 | $369.2M | -36.7% | $242.5M | 65.7% | $-105,869,000 | -28.7% |
| 2021 | $583.2M | -5.0% | $461.9M | 79.2% | $10.5M | 1.8% |
| 2020 | $614.1M | +42.9% | $482.6M | 78.6% | $-19,655,000 | -3.2% |
| 2019 | $429.8M | +87.5% | $333.7M | 77.7% | $-24,279,000 | -5.6% |
| 2018 | $229.2M | +26.6% | $174.7M | 76.2% | $-108,225,000 | -47.2% |
| 2017 | $181.1M | +39.2% | $136.2M | 75.2% | $-45,555,000 | -25.2% |
| 2016 | $130.1M | +59.1% | $95.7M | 73.6% | $-65,626,000 | -50.4% |
| 2015 | $81.8M | +50.8% | $53.9M | 65.9% | $-98,222,000 | -120.1% |
See AMRN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AMRN Undervalued?
See our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare AMRN vs AGIO
See how AMRN stacks up against sector leader Agios Pharmaceuticals, Inc..
Start ComparisonFrequently Asked Questions
Is AMRN's revenue growth accelerating or slowing?
AMRN revenue is accelerating at +17.4% year-over-year, exceeding the 5-year CAGR of -11.9%. TTM revenue reached $227M. Growth momentum has increased versus prior periods.
What is AMRN's long-term revenue growth rate?
Amarin Corporation plc's 5-year revenue CAGR of -11.9% reflects the sustained expansion pattern. Current YoY growth of +17.4% is above this long-term average.
How is AMRN's revenue distributed by segment?
AMRN reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2013-2024 are available for download. Segment mix reveals concentration and diversification trends.